查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1908775

数位病理市场规模、份额和趋势分析报告：按产品、类型、应用、治疗领域、最终用途和细分市场预测（2026-2033 年）

Digital Pathology Market Size, Share & Trends Analysis Report By Application (Academic Research, Disease Diagnosis), By Product (Software, Device), By End Use (Diagnostic Labs, Hospitals), And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

数位病理市场概况

全球数位病理市场预计到 2025 年将价值 15.3 亿美元，预计到 2033 年将达到 29.7 亿美元。

预计从 2026 年到 2033 年，该行业将以 8.6% 的复合年增长率增长，其增长动力来自癌症发病率的上升、对工作流程效率重要性的日益重视以及对更快诊断工具的需求不断增长。

此外，市场成长的驱动因素包括：市场主要企业专注于产品推出、远距病理诊断日益普及，以及由于对药物研发和精准医疗的兴趣日益浓厚而导致的医疗领域投资增加。

数位病理学产业的主要驱动力是癌症等慢性疾病的日益普遍。由于癌症的高发生率，病理学家需要病理数据来为患者制定个人化治疗方法。因此，数位病理学越来越受到病理学家的青睐，因为它能够提高诊断速度和准确性，并提供治疗建议以改善治疗效果。例如，2024 年发表在《乳癌研究》（Breast Cancer Research）上的一项研究重点介绍了 ResNet50、Transformer 和 HoverNet 等深度学习模型在提高乳癌诊断中影像增强、分割和分类准确性方面的应用。诸如此类的例子显示了该市场的巨大成长潜力。

医疗保健IT解决方案的日益普及推动了对数位病理解决方案的需求。各机构正在加速采用这些解决方案，以降低成本、简化流程、应对资源短缺并促进高效的资讯共用。此外，跨学科协作需求的不断增长以及数位化文件的日益普及也推动了这一需求。同时，数位病理解决方案在提高检查室效率方面的应用日益广泛、远距医疗的蓬勃发展以及伴随诊断和药物研发领域应用的不断增长等因素，预计也将促进市场成长。

此外，人工智慧技术正被用于提高数位影像分析的准确性。传统上，病理学家需要手动识别组织样本中的目标区域，但人工智慧现在正在实现这一过程的自动化。这项变革减少了对人工的依赖，最大限度地降低了人为错误的风险，并促进了病理学领域的自动化。

目录

第一章调查方法和范围

第二章执行摘要

第三章：数位病理市场：估计与趋势分析

  • 市场动态
  • 科技趋势分析
  • 法律规范
  • 成本结构分析
    • 实施成本
    • 价格下跌分析
  • 使用者观点分析
    • 消费行为分析
  • 打入市场策略
    • 竞争策略
  • 案例研究结果

第四章：数位病理市场：按产品分類的估算与趋势分析

  • 全球数位病理市场：产品概览
  • 全球数位病理市场：按产品分類的差异分析
  • 全球数位病理市场按产品和收入分類的估计和预测
  • 软体
  • 装置
    • 扫描器
    • 幻灯片管理系统
  • 储存系统

第五章：数位病理市场：按类型分類的估算与趋势分析

  • 全球数位病理市场：按类型分類的仪表板
  • 全球数位病理市场：按类型分類的差异分析
  • 全球数位病理市场按类型和收入估计和预测
  • 人类病理学
  • 兽医病理学

第六章：数位病理市场：按应用分類的估算与趋势分析

  • 全球数位病理市场：按应用分類的仪錶盘
  • 全球数位病理市场：按应用分類的差异分析
  • 全球数位病理市场按应用和收入分類的估计和预测
  • 药物发现与开发
  • 学术研究
  • 疾病诊断
    • 癌细胞检测
    • 其他的

第七章：数位病理市场：依治疗领域分類的估计与趋势分析

  • 全球数位病理市场：按治疗领域分類的概览
  • 全球数位病理市场：按治疗领域分類的差异分析
  • 全球数位病理市场按治疗领域和收入分類的估计和预测
  • 肿瘤学
  • 循环系统
  • 神经病学
  • 其他的

第八章：数位病理市场：依最终用途分類的估算与趋势分析

  • 全球数位病理市场：按最终用途分類的概览
  • 全球数位病理市场：按最终用途分類的差异分析
  • 全球数位病理市场按最终用途和收入分類的估计和预测
  • 医院
  • 生物技术和製药公司
  • 诊断检查室
  • 学术和研究机构

第九章：数位病理市场：区域估算与趋势分析

  • 区域仪錶板
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
    • 俄罗斯
    • 荷兰
    • 瑞士
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
    • 新加坡
    • 菲律宾
    • 马来西亚
    • 印尼
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 土耳其
    • 伊朗
    • 以色列

第十章 竞争格局

  • 参与公司概况
  • 数位病理解决方案提供者的市场分析
  • 人工智慧赋能的数位病理解决方案供应商市场分析
  • 供应商概况
    • 分销商列表
  • 2025年企业市场占有率分析
  • 公司分类
  • 策略规划
  • 数位病理解决方案综合提供者公司简介
    • Leica Biosystems Nussloch GmbH（Danaher）
    • Hamamatsu Photonics, Inc.
    • Koninklijke Philips NV
    • Olympus Corporation
    • F. Hoffmann-La Roche Ltd.
    • Mikroscan Technologies, Inc.
    • Epredia（3DHISTECH Ltd.）
    • Visiopharm A/S
    • Huron Technologies International Inc.
    • ContextVision AB
    • CellaVision
    • HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD.（MORPHOGO）
    • West Medica Produktions-und Handels-GmbH（West Medica）
    • aetherAI
    • IBEX（IBEX MEDICAL ANALYTICS）
    • SigTuple Technologies Private Limited Morphle Labs, Inc
    • Morphle Labs, Inc
    • Bionovation Biotech, Inc.
    • Scopio labs
    • Inspirata, Inc
    • Path Hub
    • Sectra AB
    • Agfa-Gevaert Group
    • OptraScan
    • Agilent Technologies, Inc.
    • KFBIO
  • 提供人工智慧数位病理解决方案的公司简介
    • Aiosyn
    • Proscia Inc.
    • EVIDENT
    • Aignostics, Inc.
    • Aiforia/Aiforia Technologies PLC
    • Qritive
    • Mindpeak GmbH
    • Dedalus SpA
    • Gestalt
    • CGI Inc. Overview
Product Code: 978-1-68038-386-7

Digital Pathology Market Summary

The global digital pathology market size was estimated at USD 1.53 billion in 2025 and is projected to reach USD 2.97 billion by 2033, growing at a CAGR of 8.6% from 2026 to 2033. This is attributed to rising prevalence of cancer, increasing focus on improving the efficiency of workflow, and growing demand for faster diagnostic tools.

Moreover, rising investments in healthcare aided by major key players operating in the market focusing on new launches, increasing adoption of telepathology, and an increasing focus on drug discovery and precision medicine is propelling the market growth.

The digital pathology industry is predominantly driven by the growing prevalence of chronic diseases such as cancer. As a consequence of the high prevalence of cancer, pathologists require pathology data that can facilitate customizing of therapies for patients. Therefore, digital pathology is increasingly preferred by pathologists, as it accelerates the diagnosis rate, enhances diagnostic accuracy, and provides therapeutic recommendations to improve patient outcomes. For instance, a 2024 study published in Breast Cancer Research highlights the application of deep learning models such as ResNet50, Transformer, and Hover-net in enhancing image enhancement, segmentation, and classification for breast cancer diagnosis. Such instances signify the growth potential of the market.

Rising adoption of healthcare IT solutions is fueling the demand for digital pathology solutions. Organizations are increasingly implementing them to cut costs, streamline processes, overcome resource bottlenecks, and facilitate efficient content sharing. A growing necessity for collaborations and the expanding use of digital documentation across various scientific disciplines also drives the demand. In addition, factors such as heightened adoption to enhance laboratory efficiency, a surge in teleconsultations, and increased applications in companion diagnostics and drug discovery are expected to contribute to the market's growth.

Additionally, AI is being leveraged to enhance the analysis of digital images. Previously, pathologists had to identify regions of interest within tissue samples manually, but AI is now automating this process. This shift reduces the reliance on manual labor, minimizing the risk of human error and promoting greater automation in pathology practices.

Global Digital Pathology Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global digital pathology market based on product, application, therapeutic area, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Device
    • Scanners
    • Slide Management Systems
  • Storage System
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Human Pathology
  • Veterinary Pathology
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery & Development
  • Academic Research
  • Disease Diagnosis
    • Cancer Cell Detection
    • Others
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Cardiovascular
  • Neurology
  • Others (Including dermatology, infectious diseases, gastrointestinal, etc.)
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Biotech & Pharma Companies
  • Diagnostic Labs
  • Academic & Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Russia
    • Spain
    • Netherlands
    • Switzerland
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Indonesia
    • Thailand
    • Australia
    • South Korea
    • Philippines
    • Malaysia
    • Singapore
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey
    • Iran
    • United Arab Emirates
    • Israel
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. Application
    • 1.2.4. Therapeutic Area
    • 1.2.5. End Use
  • 1.3. Regional scope
  • 1.4. Estimates and forecasts timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased database
    • 1.6.2. GVR's internal database
    • 1.6.3. Secondary sources
    • 1.6.4. Primary research
    • 1.6.5. Details of primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data analysis models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Primary Sources
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Digital Pathology Market Snapshot
  • 2.2. Digital Pathology Market Segment Snapshot
  • 2.3. Digital Pathology Market Competitive Landscape Snapshot

Chapter 3. Digital Pathology Market: Component Estimates & Trend Analysis

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
      • 3.1.1.1. Increasing prevalence of chronic diseases
      • 3.1.1.2. Higher cost-efficiency
      • 3.1.1.3. Rapid technological advancements
      • 3.1.1.4. Increasing demand for integrated healthcare systems and patient-centric care
      • 3.1.1.5. Growing adoption of digital pathology solutions in veterinary care practices
      • 3.1.1.6. Rapid technological advancements in digital pathology solutions in veterinary field
    • 3.1.2. Market restraint analysis
      • 3.1.2.1. Lack of skilled professionals
      • 3.1.2.2. High cost of implementing digital pathology solutions
    • 3.1.3. Market opportunity analysis
    • 3.1.4. Market challenges analysis
    • 3.1.5. Industry Analysis - Porter's Five Forces Analysis
      • 3.1.5.1. Supplier power
      • 3.1.5.2. Buyer power
      • 3.1.5.3. Substitution threat
      • 3.1.5.4. Threat of new entrant
      • 3.1.5.5. Competitive rivalry
    • 3.1.6. PESTEL Analysis
  • 3.2. Technology Trend Analysis
  • 3.3. Regulatory Framework
  • 3.4. Cost Structure Analysis
    • 3.4.1. Cost of implementation
    • 3.4.2. Price erosion analysis
  • 3.5. User Perspective Analysis
    • 3.5.1. Consumer behavior analysis
  • 3.6. Market Entry Strategies
    • 3.6.1. Competitive strategies
  • 3.7. Case Study Insights

Chapter 4. Digital Pathology Market: Product Estimates & Trend Analysis

  • 4.1. Global Digital Pathology Market: Product Dashboard
  • 4.2. Global Digital Pathology Market: Product Movement Analysis
  • 4.3. Global Digital Pathology Market Estimates and Forecasts, By Product, Revenue (USD Million)
  • 4.4. Software
    • 4.4.1. Software market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Device
    • 4.5.1. Devices market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.2. Scanners
      • 4.5.2.1. Scanners market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.5.3. Slide Management System
      • 4.5.3.1. Slide management system market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Storage System
    • 4.6.1. Storage system market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Digital Pathology Market: Type Estimates & Trend Analysis

  • 5.1. Global Digital Pathology Market: Type Dashboard
  • 5.2. Global Digital Pathology Market: Type Movement Analysis
  • 5.3. Global Digital Pathology Market Estimates and Forecasts, By Type, Revenue (USD Million)
  • 5.4. Human Pathology
    • 5.4.1. Human pathology market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Veterinary Pathology
    • 5.5.1. Veterinary pathology market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Digital Pathology Market: Application Estimates & Trend Analysis

  • 6.1. Global Digital Pathology Market: Application Dashboard
  • 6.2. Global Digital Pathology Market: Application Movement Analysis
  • 6.3. Global Digital Pathology Market Estimates and Forecasts, By Application, Revenue (USD Million)
  • 6.4. Drug Discovery & Development
    • 6.4.1. Drug discovery & development market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Academic Research
    • 6.5.1. Academic research market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Disease Diagnosis
    • 6.6.1. Disease diagnosis market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.2. Cancer Cell Detection
      • 6.6.2.1. Cancer cell detection market estimates and forecasts, 2021 to 2033 (USD Million)
    • 6.6.3. Others
      • 6.6.3.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Digital Pathology Market: Therapeutic Area Estimates & Trend Analysis

  • 7.1. Global Digital Pathology Market: Therapeutic Area Dashboard
  • 7.2. Global Digital Pathology Market: Therapeutic Area Movement Analysis
  • 7.3. Global Digital Pathology Market Estimates and Forecasts, By Therapeutic Area, Revenue (USD Million)
  • 7.4. Oncology
    • 7.4.1. Oncology market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Cardiovascular
    • 7.5.1. Cardiovascular market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Neurology
    • 7.6.1. Neurology market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Digital Pathology Market: End Use Estimates & Trend Analysis

  • 8.1. Global Digital Pathology Market: End Use Dashboard
  • 8.2. Global Digital Pathology Market: End Use Movement Analysis
  • 8.3. Global Digital Pathology Market Estimates and Forecasts, By End Use, Revenue (USD Million)
  • 8.4. Hospitals
    • 8.4.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5. Biotech & Pharma Companies
    • 8.5.1. Biotech & pharma companies market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6. Diagnostic Labs
    • 8.6.1. Diagnostic labs market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7. Academic & research institutes
    • 8.7.1. Academic & Research Institutes market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Digital Pathology Market: Regional Estimates & Trend Analysis by Product and End Use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.6. Denmark
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.8. Norway
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.9. Russia
      • 9.4.9.1. Key country dynamics
      • 9.4.9.2. Regulatory framework
      • 9.4.9.3. Competitive scenario
      • 9.4.9.4. Russia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.10. Netherlands
      • 9.4.10.1. Key country dynamics
      • 9.4.10.2. Regulatory framework
      • 9.4.10.3. Competitive scenario
      • 9.4.10.4. Netherlands market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.4.11. Switzerland
      • 9.4.11.1. Key country dynamics
      • 9.4.11.2. Regulatory framework
      • 9.4.11.3. Competitive scenario
      • 9.4.11.4. Switzerland market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.4. South Korea
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.5. Thailand
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.6. Australia
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.7. Singapore
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Regulatory framework
      • 9.5.7.3. Competitive scenario
      • 9.5.7.4. Singapore market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.8. Philippines
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Regulatory framework
      • 9.5.8.3. Competitive scenario
      • 9.5.8.4. Philippines market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.9. Malaysia
      • 9.5.9.1. Key country dynamics
      • 9.5.9.2. Regulatory framework
      • 9.5.9.3. Competitive scenario
      • 9.5.9.4. Malaysia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.5.10. Indonesia
      • 9.5.10.1. Key country dynamics
      • 9.5.10.2. Regulatory framework
      • 9.5.10.3. Competitive scenario
      • 9.5.10.4. Indonesia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.6.3. Mexico
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.7.5. Turkey
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. Turkey market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.7.6. Iran
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Iran market estimates and forecasts, 2021 to 2033 (USD Million)
    • 9.7.7. Israel
      • 9.7.7.1. Key country dynamics
      • 9.7.7.2. Regulatory framework
      • 9.7.7.3. Competitive scenario
      • 9.7.7.4. Israel market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Overview
  • 10.2. Company Market Position Analysis of Overall Digital Pathology Solution Providers
  • 10.3. Company Market Position Analysis of AI-enabled Digital Pathology Solution Providers
  • 10.4. Vendor Landscape
    • 10.4.1. List of Distributors
  • 10.5. Company Market Share Analysis, 2025
  • 10.6. Company Categorization
  • 10.7. Strategy Mapping
  • 10.8. Company Profiles of Overall Digital Pathology Solution Providers
    • 10.8.1. Leica Biosystems Nussloch GmbH (Danaher)
      • 10.8.1.1. Overview
      • 10.8.1.2. Financial performance
      • 10.8.1.3. Product benchmarking
      • 10.8.1.4. Strategic initiatives
    • 10.8.2. Hamamatsu Photonics, Inc.
      • 10.8.2.1. Overview
      • 10.8.2.2. Financial performance
      • 10.8.2.3. Product benchmarking
      • 10.8.2.4. Strategic initiatives
    • 10.8.3. Koninklijke Philips N.V.
      • 10.8.3.1. Overview
      • 10.8.3.2. Financial performance
      • 10.8.3.3. Product benchmarking
      • 10.8.3.4. Strategic initiatives
    • 10.8.4. Olympus Corporation
      • 10.8.4.1. Overview
      • 10.8.4.2. Financial performance
      • 10.8.4.3. Product benchmarking
      • 10.8.4.4. Strategic initiatives
    • 10.8.5. F. Hoffmann-La Roche Ltd.
      • 10.8.5.1. Overview
      • 10.8.5.2. Financial performance
      • 10.8.5.3. Product benchmarking
      • 10.8.5.4. Strategic initiatives
    • 10.8.6. Mikroscan Technologies, Inc.
      • 10.8.6.1. Overview
      • 10.8.6.2. Financial performance
      • 10.8.6.3. Product benchmarking
      • 10.8.6.4. Strategic initiatives
    • 10.8.7. Epredia (3DHISTECH Ltd.)
      • 10.8.7.1. Overview
      • 10.8.7.2. Financial performance
      • 10.8.7.3. Product benchmarking
      • 10.8.7.4. Strategic initiatives
    • 10.8.8. Visiopharm A/S
      • 10.8.8.1. Overview
      • 10.8.8.2. Financial performance
      • 10.8.8.3. Product benchmarking
      • 10.8.8.4. Strategic initiatives
    • 10.8.9. Huron Technologies International Inc.
      • 10.8.9.1. Overview
      • 10.8.9.2. Financial performance
      • 10.8.9.3. Product benchmarking
      • 10.8.9.4. Strategic initiatives
    • 10.8.10. ContextVision AB
      • 10.8.10.1. Overview
      • 10.8.10.2. Financial performance
      • 10.8.10.3. Product benchmarking
      • 10.8.10.4. Strategic initiatives
    • 10.8.11. CellaVision
      • 10.8.11.1. Overview
      • 10.8.11.2. Financial performance
      • 10.8.11.3. Product benchmarking
      • 10.8.11.4. Strategic initiatives
    • 10.8.12. HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
      • 10.8.12.1. Overview
      • 10.8.12.2. Financial performance
      • 10.8.12.3. Product benchmarking
      • 10.8.12.4. Strategic initiatives
    • 10.8.13. West Medica Produktions- und Handels- GmbH (West Medica)
      • 10.8.13.1. Overview
      • 10.8.13.2. Financial performance
      • 10.8.13.3. Product benchmarking
      • 10.8.13.4. Strategic initiatives
    • 10.8.14. aetherAI
      • 10.8.14.1. Overview
      • 10.8.14.2. Financial performance
      • 10.8.14.3. Product benchmarking
      • 10.8.14.4. Strategic initiatives
    • 10.8.15. IBEX (IBEX MEDICAL ANALYTICS)
      • 10.8.15.1. Overview
      • 10.8.15.2. Financial performance
      • 10.8.15.3. Product benchmarking
      • 10.8.15.4. Strategic initiatives
    • 10.8.16. SigTuple Technologies Private Limited Morphle Labs, Inc
      • 10.8.16.1. Overview
      • 10.8.16.2. Financial performance
      • 10.8.16.3. Product benchmarking
      • 10.8.16.4. Strategic initiatives
    • 10.8.17. Morphle Labs, Inc
      • 10.8.17.1. Overview
      • 10.8.17.2. Financial performance
      • 10.8.17.3. Product benchmarking
      • 10.8.17.4. Strategic initiatives
    • 10.8.18. Bionovation Biotech, Inc.
      • 10.8.18.1. Overview
      • 10.8.18.2. Financial performance
      • 10.8.18.3. Product benchmarking
      • 10.8.18.4. Strategic initiatives
    • 10.8.19. Scopio labs
      • 10.8.19.1. Overview
      • 10.8.19.2. Financial performance
      • 10.8.19.3. Product benchmarking
      • 10.8.19.4. Strategic initiatives
    • 10.8.20. Inspirata, Inc
      • 10.8.20.1. Overview
      • 10.8.20.2. Financial performance
      • 10.8.20.3. Product benchmarking
      • 10.8.20.4. Strategic initiatives
    • 10.8.21. Path Hub
      • 10.8.21.1. Overview
      • 10.8.21.2. Financial performance
      • 10.8.21.3. Product benchmarking
      • 10.8.21.4. Strategic initiatives
    • 10.8.22. Sectra AB
      • 10.8.22.1. Overview
      • 10.8.22.2. Financial performance
      • 10.8.22.3. Product benchmarking
      • 10.8.22.4. Strategic initiatives
    • 10.8.23. Agfa-Gevaert Group
      • 10.8.23.1. Overview
      • 10.8.23.2. Financial performance
      • 10.8.23.3. Product benchmarking
      • 10.8.23.4. Strategic initiatives
    • 10.8.24. OptraScan
      • 10.8.24.1. Overview
      • 10.8.24.2. Financial performance
      • 10.8.24.3. Product benchmarking
      • 10.8.24.4. Strategic initiatives
    • 10.8.25. Agilent Technologies, Inc.
      • 10.8.25.1. Overview
      • 10.8.25.2. Financial performance
      • 10.8.25.3. Product benchmarking
      • 10.8.25.4. Strategic initiatives
    • 10.8.26. KFBIO
      • 10.8.26.1. Overview
      • 10.8.26.2. Financial performance
      • 10.8.26.3. Product benchmarking
      • 10.8.26.4. Strategic initiatives
  • 10.9. Company Profiles of AI-enabled Digital Pathology Solution Providers
    • 10.9.1. Aiosyn
      • 10.9.1.1. Overview
      • 10.9.1.2. Financial performance
      • 10.9.1.3. Product benchmarking
      • 10.9.1.4. Strategic initiatives
    • 10.9.2. Proscia Inc.
      • 10.9.2.1. Overview
      • 10.9.2.2. Financial performance
      • 10.9.2.3. Product benchmarking
      • 10.9.2.4. Strategic initiatives
    • 10.9.3. EVIDENT
      • 10.9.3.1. Overview
      • 10.9.3.2. Financial performance
      • 10.9.3.3. Product benchmarking
      • 10.9.3.4. Strategic initiatives
    • 10.9.4. Aignostics, Inc.
      • 10.9.4.1. Overview
      • 10.9.4.2. Financial performance
      • 10.9.4.3. Product benchmarking
      • 10.9.4.4. Strategic initiatives
    • 10.9.5. Aiforia/ Aiforia Technologies PLC
      • 10.9.5.1. Overview
      • 10.9.5.2. Financial performance
      • 10.9.5.3. Product benchmarking
      • 10.9.5.4. Strategic initiatives
    • 10.9.6. Qritive
      • 10.9.6.1. Overview
      • 10.9.6.2. Financial performance
      • 10.9.6.3. Product benchmarking
      • 10.9.6.4. Strategic initiatives
    • 10.9.7. Mindpeak GmbH
      • 10.9.7.1. Overview
      • 10.9.7.2. Financial performance
      • 10.9.7.3. Product benchmarking
      • 10.9.7.4. Strategic initiatives
    • 10.9.8. Dedalus S.p.A
      • 10.9.8.1. Overview
      • 10.9.8.2. Financial performance
      • 10.9.8.3. Product benchmarking
      • 10.9.8.4. Strategic initiatives
    • 10.9.9. Gestalt
      • 10.9.9.1. Overview
      • 10.9.9.2. Financial performance
      • 10.9.9.3. Product benchmarking
      • 10.9.9.4. Strategic initiatives
    • 10.9.10 CGI Inc. Overview
      • 10.9.10.1. Financial performance
      • 10.9.10.2. Product benchmarking
      • 10.9.10.3. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Digital pathology market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 6 North America Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 7 North America Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S. Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 9 U.S. Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 10 U.S. Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 11 U.S. Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 12 U.S. Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 16 Canada Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 17 Canada Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 18 Europe Digital pathology market, by region, 2021 - 2033 (USD Million)
  • Table 19 Europe Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 20 Europe Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 21 Europe Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 22 Europe Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 23 Europe Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Germany Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 25 Germany Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 26 Germany Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 27 Germany Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 28 Germany Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 29 UK Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 30 UK Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 31 UK Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 32 UK Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 33 UK Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 34 France Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 35 France Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 36 France Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 37 France Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 38 France Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Italy Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 40 Italy Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 41 Italy Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 42 Italy Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 43 Italy Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Spain Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 45 Spain Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 46 Spain Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 47 Spain Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 48 Spain Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Denmark Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 50 Denmark Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 51 Denmark Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 52 Denmark Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 53 Denmark Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Sweden Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 56 Sweden Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 57 Sweden Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 58 Sweden Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 59 Norway Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 60 Norway Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 61 Norway Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 62 Norway Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 63 Norway Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 64 Russia Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 65 Russia Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 66 Russia Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 67 Russia Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 68 Russia Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Netherlands Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 70 Netherlands Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 71 Netherlands Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 72 Netherlands Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 73 Netherlands Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 74 Switzerland Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 75 Switzerland Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 76 Switzerland Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 77 Switzerland Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 78 Switzerland Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific Digital pathology market, by region, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 81 Asia Pacific Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 82 Asia Pacific Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 83 Asia Pacific Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 84 Asia Pacific Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 85 China Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 86 China Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 87 China Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 88 China Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 89 China Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 90 Japan Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 91 Japan Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 92 Japan Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 93 Japan Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 94 Japan Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 95 India Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 96 India Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 97 India Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 98 India Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 99 India Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 100 South Korea Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 101 South Korea Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 102 South Korea Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 103 South Korea Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 104 South Korea Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 105 Australia Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 106 Australia Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 107 Australia Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 108 Australia Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 109 Australia Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 110 Thailand Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 111 Thailand Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 112 Thailand Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 113 Thailand Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 114 Thailand Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 115 Indonesia Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 116 Indonesia Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 117 Indonesia Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 118 Indonesia Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 119 Indonesia Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 120 Philippines Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 121 Philippines Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 122 Philippines Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 123 Philippines Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 124 Philippines Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 125 Malaysia Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 126 Malaysia Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 127 Malaysia Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 128 Malaysia Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 129 Malaysia Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 130 Singapore Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 131 Singapore Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 132 Singapore Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 133 Singapore Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 134 Singapore Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 135 Latin America Digital pathology market, by region, 2021 - 2033 (USD Million)
  • Table 136 Latin America Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 137 Latin America Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 138 Latin America Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 139 Latin America Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 140 Latin America Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 141 Brazil Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 142 Brazil Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 143 Brazil Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 144 Brazil Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 145 Brazil Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 146 Argentina Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 147 Argentina Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 148 Argentina Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 149 Argentina Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 150 Argentina Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 151 Mexico Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 152 Mexico Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 153 Mexico Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 154 Mexico Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 155 Mexico Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 156 MEA Digital pathology market, by region, 2021 - 2033 (USD Million)
  • Table 157 MEA Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 158 MEA Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 159 MEA Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 160 MEA Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 161 MEA Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 162 South Africa Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 163 South Africa Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 164 South Africa Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 165 South Africa Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 166 South Africa Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 167 Saudi Arabia Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 168 Saudi Arabia Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 169 Saudi Arabia Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 170 Saudi Arabia Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 171 Saudi Arabia Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 172 UAE Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 173 UAE Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 174 UAE Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 175 UAE Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 176 UAE Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 177 Kuwait Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 178 Kuwait Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 179 Kuwait Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 180 Kuwait Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 181 Kuwait Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 182 Israel Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 183 Israel Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 184 Israel Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 185 Israel Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 186 Israel Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 187 Turkey Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 188 Turkey Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 189 Turkey Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 190 Turkey Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 191 Turkey Digital pathology market, by end use, 2021 - 2033 (USD Million)
  • Table 192 Iran Digital pathology market, by product, 2021 - 2033 (USD Million)
  • Table 193 Iran Digital pathology market, by application, 2021 - 2033 (USD Million)
  • Table 194 Iran Digital pathology market, by therapeutic area, 2021 - 2033 (USD Million)
  • Table 195 Iran Digital pathology market, by type, 2021 - 2033 (USD Million)
  • Table 196 Iran Digital pathology market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Digital pathology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Commodity flow analysis
  • Fig. 5 Digital Pathology Market snapshot
  • Fig. 6 Digital Pathology Market segment snapshot (Part 1)
  • Fig. 7 Digital Pathology Market competitive landscape snapshot
  • Fig. 8 Market research process
  • Fig. 9 Digital pathology market dynamics
  • Fig. 10 Digital pathology market: Porter's five forces analysis
  • Fig. 11 Digital pathology market: PESTLE analysis
  • Fig. 12 Digital pathology market: Product outlook key takeaways (USD Million)
  • Fig. 13 Digital pathology market: Product movement analysis, 2025 & 2033 (USD Million)
  • Fig. 14 Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Device market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Scanners market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Slide management system market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Storage system market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Digital pathology market: Type outlook key takeaways (USD Million)
  • Fig. 20 Digital pathology market: Type movement analysis, 2025 & 2033 (USD Million)
  • Fig. 21 Human pathology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Veterinary pathology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Digital pathology market: Application outlook key takeaways (USD Million)
  • Fig. 24 Digital pathology market: Application movement analysis, 2025 & 2033 (USD Million)
  • Fig. 25 Drug discovery & development market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Academic research market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Disease diagnosis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Cancer cell detection market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Digital pathology market: Therapeutic area outlook key takeaways (USD Million)
  • Fig. 31 Digital pathology market: Therapeutic area movement analysis, 2025 & 2033 (USD Million)
  • Fig. 32 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Cardiovascular market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Neurology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Digital pathology market: End use outlook key takeaways (USD Million)
  • Fig. 37 Digital pathology market: End use movement analysis, 2025 & 2033 (USD Million)
  • Fig. 38 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Biotech & pharma companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Diagnostic labs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 Digital Pathology Market: Regional outlook, Part 1
  • Fig. 44 Digital Pathology Market: Regional outlook, 2025 & 2033, Part 2
  • Fig. 45 North America Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 U.S. Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Canada Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 50 Europe Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 UK Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Germany Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 France Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Italy Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Spain Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Sweden Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Denmark Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Norway Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Netherlands Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Switzerland Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Russia Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 73 Asia Pacific Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Japan Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 China Digital pathology software market, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 India Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Australia Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Thailand Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 South Korea Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Indonesia Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Philippines Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Malaysia Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Singapore Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 94 Latin America Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Brazil Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Argentina Digital pathology software market, 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Mexico Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 101 MEA Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 South Africa Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Saudi Arabia Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 UAE Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Kuwait Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 110 Key country dynamics
  • Fig. 111 Turkey Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 112 Key country dynamics
  • Fig. 113 Iran Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 114 Key country dynamics
  • Fig. 115 Israel Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 116 Company Categorization (Part 1)
  • Fig. 117 Company Categorization (Part 2)
  • Fig. 118 Company market position analysis, 2025 (Part 1)
  • Fig. 119 Company market position analysis, 2025 (Part 2)
  • Fig. 120 Strategic Framework